Alzenau, Germany

Jurgen Rawert


Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 27(Granted Patents)


Location History:

  • Werther, DE (1998)
  • Alzenau, DE (1999 - 2001)

Company Filing History:


Years Active: 1998-2001

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Jurgen Rawert: Innovator in Pharmaceutical Advancements

Introduction

Jurgen Rawert is a notable inventor based in Alzenau, Germany. He has made significant contributions to the field of pharmaceuticals, holding a total of five patents. His work focuses on innovative solutions for drug administration and treatment methodologies.

Latest Patents

One of Jurgen Rawert's latest patents is related to pharmaceutical forms for the oral administration of mesna. This invention includes tablets, film-coated tablets, pellets, or granules that comprise at least 88% of mesna, produced by granulation with up to 15% of water. Additionally, he has developed formulations that include at least 80% of mesna, produced by direct compression or compaction, without the use of organic solvents. Another significant patent addresses means for treating prostate hypertrophy and prostate cancer. This therapeutic management regime employs Cetrorelix, either alone or in combination with alpha-reductase inhibitors or alpha-receptor blocking agents. The regimen aims to reduce prostate volume while minimizing side effects associated with testosterone levels.

Career Highlights

Jurgen Rawert is associated with Asta Medica, Aktiengesellschaft, where he has contributed to various pharmaceutical innovations. His expertise in drug formulation and therapeutic management has positioned him as a key figure in the industry.

Collaborations

Throughout his career, Jurgen has collaborated with notable colleagues, including Jurgen Engel and Thomas Reissmann. These partnerships have fostered a collaborative environment that enhances innovation and research in pharmaceuticals.

Conclusion

Jurgen Rawert's contributions to pharmaceutical inventions demonstrate his commitment to advancing medical treatments. His innovative patents reflect a deep understanding of drug formulation and therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…